AMGEVITA adalimumab (rch) 40mg/0.8mL injection solution syringe within a pen injector - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
AMGEVITA adalimumab (rch) 40mg/0.8mL injection solution syringe within a pen injector
AUST R: 273536
Active ingredients:
Adalimumab

Dosage form:
Injection, solution

Sponsor:
Amgen Australia Pty Ltd

Phone:
1800 803 638

Deletion from market:
27 Oct 2026

Shortage status:
To be discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability

Management action:
This product will be replaced by AMGEVITA adalimumab (rch) 40mg/0.4mL injection solution syringe within a pen injector (ARTG ID 484553).